Press "Enter" to skip to content

New patent expiration for Sucampo Pharma drug AMITIZA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Sucampo Pharma drug AMITIZA

Annual Drug Patent Expirations for AMITIZA
Annual Drug Patent Expirations for AMITIZA

Amitiza is a drug marketed by Sucampo Pharma Llc and is included in one NDA. It is available from four suppliers. There are ten patents protecting this drug and one Paragraph IV challenge.

AMITIZA drug price trends.

Drug patent litigation for AMITIZA.

This drug has one hundred and sixty-three patent family members in twenty-seven countries.

The generic ingredient in AMITIZA is lubiprostone. Four suppliers are listed for this compound. Additional details are available on the lubiprostone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Sucampo Pharma drug AMITIZA
Online Certificate Course

Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

  • When will key drug patents expire?
  • How can I find, evaluate, and plan for generic market entry opportunities?
  • How can I find proprietary out-of-court settlements and deal terms?
DrugPatentWatch - Make Better Decisions